Ausgabe 2/2018
Inhalt (5 Artikel)
The SAFE pathway for cardioprotection: is this a promising target?
Nkanyiso Hadebe, Martin Cour, Sandrine Lecour
Molecular imaging of cardiac remodelling after myocardial infarction
Daniel Curley, Begoña Lavin Plaza, Ajay M. Shah, René M. Botnar
Phosphorylation of vasodilator-stimulated phosphoprotein contributes to myocardial ischemic preconditioning
David Köhler, Sofia-Iris Bibli, Lothar P. Klammer, Judith M. Roth, Rainer Lehmann, Ingrid Fleming, Tiago F. Granja, Andreas Straub, Peter M. Benz, Peter Rosenberger
RETRACTED ARTICLE: Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway
Liang Liu, Xian Jin, Cui-Fen Hu, Ya-Ping Zhang, Zhong’e Zhou, Rong Li, Cheng-Xing Shen
Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling
Refaat A. Eid, Mahmoud A. Alkhateeb, Samy Eleawa, Fahaid H. Al-Hashem, Mubarak Al-Shraim, Attalla Farag El-kott, Mohamed Samir Ahmed Zaki, Mohammad A. Dallak, Hussain Aldera